← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2018Last known activity
Nov 3, 2025
Timeline
2010s
- Jan 1, 2016
Chongqing Precision Biotech Co., Ltd— Founded
Drugs by trial phase (21 distinct, 53 trials)
Phase 2 (8 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Leukemia
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Pancreatic Neoplasms
- Stomach Neoplasms
Recent trials (50)
- NCT07247396CollaboratorPhase 1Nov 3, 2025
- NCT07250386CollaboratorPhase 1Oct 13, 2025
- NCT07181720Lead sponsorPhase 1Sep 12, 2025
- NCT07179692Lead sponsorPhase 1Sep 12, 2025
- NCT07184450Lead sponsorPhase 1Sep 1, 2025
- NCT06992583Lead sponsorPhase 1May 8, 2025
- NCT06945523Lead sponsorPhase 1Apr 28, 2025
- NCT06934447CollaboratorPhase 1Apr 25, 2025
- NCT06892145Lead sponsorPhase 1Apr 2, 2025
- NCT06909474Lead sponsorPhase 1Mar 27, 2025
- NCT06903117Lead sponsorPhase 1Mar 24, 2025
- NCT06768151Lead sponsorPhase 1Dec 12, 2024
- NCT06690827Lead sponsorPhase 1Nov 13, 2024
- NCT06686524Lead sponsorPhase 1Nov 11, 2024
- NCT06641024Lead sponsorPhase 1Nov 1, 2024
Details
- Founded
- Chongqing, CN Jan 1, 2016
- Last known activity
- Nov 3, 2025